| 000 | 01497 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515080547.0 | ||
| 264 | 0 | _c20071107 | |
| 008 | 200711s 0 0 eng d | ||
| 022 | _a1071-7544 | ||
| 024 | 7 |
_a10.1080/10717540601098823 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHeikkilä, T | |
| 245 | 0 | 0 |
_aEvaluation of mesoporous TCPSi, MCM-41, SBA-15, and TUD-1 materials as API carriers for oral drug delivery. _h[electronic resource] |
| 260 |
_bDrug delivery _cAug 2007 |
||
| 300 |
_a337-47 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadministration & dosage |
| 650 | 0 | 4 |
_aDrug Carriers _xchemistry |
| 650 | 0 | 4 | _aHydrogen-Ion Concentration |
| 650 | 0 | 4 |
_aIbuprofen _xadministration & dosage |
| 650 | 0 | 4 | _aPermeability |
| 650 | 0 | 4 | _aPorosity |
| 650 | 0 | 4 |
_aSilicon _xchemistry |
| 650 | 0 | 4 |
_aSilicon Dioxide _xchemistry |
| 650 | 0 | 4 | _aSolubility |
| 650 | 0 | 4 | _aX-Ray Diffraction |
| 700 | 1 | _aSalonen, J | |
| 700 | 1 | _aTuura, J | |
| 700 | 1 | _aKumar, N | |
| 700 | 1 | _aSalmi, T | |
| 700 | 1 | _aMurzin, D Yu | |
| 700 | 1 | _aHamdy, M S | |
| 700 | 1 | _aMul, G | |
| 700 | 1 | _aLaitinen, L | |
| 700 | 1 | _aKaukonen, A M | |
| 700 | 1 | _aHirvonen, J | |
| 700 | 1 | _aLehto, V-P | |
| 773 | 0 |
_tDrug delivery _gvol. 14 _gno. 6 _gp. 337-47 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/10717540601098823 _zAvailable from publisher's website |
| 999 |
_c17232781 _d17232781 |
||